Clinical Trials Logo
  1. Home
  2. Thrombosis
  3. NCT03292107
  4. Details
NCT03292107 Clinical Trial

Study on Management Thrombosis in Greek Cancer Patients

Thrombosis Clinical Trial

— GMaT  

Official title:
Study on Management Thrombosis in Greek Cancer Patients (GMaT - Greek Management Thrombosis)

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03292107
Other study ID # Management Thrombosis
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 1, 2016
Est. completion date February 28, 2018

Study information
Verified date April 2019
Source Hellenic Society of Medical Oncology
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Study on Management Thrombosis in Greek cancer patients

Description:

The approach that Medical Oncologists encounter the prospect of a coagulation event occurrence in cancer patients.

Recruitment information / eligibility
Status Completed
Enrollment 500
Est. completion date February 28, 2018
Est. primary completion date December 31, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria

- All patients diagnosed with histologically confirmed solid tumors that are under anticoagulation therapy, during the study timeline.

- Age = 18 years

- Signed informed consent

Exclusion Criteria

- Initiation of anticoagulation therapy before the initiation of the study in 2016

- Age <18 years

- No signed informed consent

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Greece Hellenic Society of Medical Oncology Athens

Sponsors (1)
Lead Sponsor Collaborator
Hellenic Society of Medical Oncology

Country where clinical trial is conducted

Greece, 

Outcome
Type Measure Description Time frame Safety issue
Primary The clinical practice for patients under anticoagulation regime Documentation of the clinical practice for patients under anticoagulation regime, for prophylaxis or treatment, in patients with solid tumors, for one year following the protocol initiation date, including high-risk patients as defined in the protocol. 1 YEAR
See also
  Status Clinical Trial Phase
Completed NCT03826043 - THrombo-Embolic Event in Onco-hematology N/A
Recruiting NCT04398628 - ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Completed NCT05426564 - Exploratory Assessment of the Quantra® System in Adult ECMO Patients
Not yet recruiting NCT05830916 - Diagnostic Role of Antiphospholipid Antibodies and Microparticles in Immune Thrombocytopenic Patients With Thrombosis
Recruiting NCT02972385 - Pharmacogenomics of Warfarin in Hispanics and Latinos
Completed NCT02917213 - Imaging Silent Brain Infarct And Thrombosis in Acute Myocardial Infarction
Completed NCT02439190 - CV004-007 Thrombosis Chamber Study Phase 1
Completed NCT02526628 - Thrombosis and Neurocognition in Klinefelter Syndrome
Completed NCT02341638 - Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy Subjects Phase 1
Completed NCT01855516 - Partial Thromboplastin Time After 72 Hours of Antithrombotic Prophylaxis Using Unfractionated Heparin N/A
Unknown status NCT00983112 - Evicel Study on the Peri-operative Bleeding in Total Knee Prothesis Surgery Phase 4
Completed NCT00412464 - Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis Phase 1
Completed NCT00479362 - Anticoagulant Therapy During Pacemaker Implantation Phase 4
Completed NCT00346424 - Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters Phase 3
Terminated NCT00303420 - Alteplase for Blood Flow Restoration in Hemodialysis Catheters Phase 4
Completed NCT00143715 - Oral Vitamin K for Warfarin Associated Coagulopathy Phase 3
Completed NCT00039858 - Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin Phase 4
Completed NCT00007410 - Genetic Architecture of Plasma T-PA and PAI-1 N/A
Completed NCT00000538 - Dietary Effects on Lipoproteins and Thrombogenic Activity Phase 3
Completed NCT00005436 - Lupus Cohort--Thrombotic Events and Coronary Artery Disease N/A